Genmab has completed its $1.8 billion acquisition of ProfoundBio, a clinical-stage biotechnology company developing next-generation antibody-drug conjugates (ADCs) and...
Danish drugmaker Genmab has agreed to buy privately-owned US biotechnology company ProfoundBio for $1.8 billion. ProfoundBio develops novel ADCs and ADC technologies for...
17.06.2020
- US drugmaker AbbVie has signed two separate collaboration agreements, one with Denmark’s Genmab and the other with China’s Jacobio Pharmaceuticals, for developing and...
18.09.2012
- Johnson & Johnson is stepping a drive to tap into emerging healthcare technology by establishing new innovation centres in four of the world's biotech hot spots - California...
28.10.2010
- Danish-listed biotech Genmab is vulnerable to a takeover due to its current low share price, and the company needs more time to develop its full potential, its chief executive told...
